Abstract. Bone marrow mesenchymal stem cell (BMSC) transplants are promising for the treatment of certain central nervous system diseases. However, oxidative stress is one of the major factors that may limit the survival of the transplanted BMSCs. The present study investigated the effect of pretreatment with gigantol on hydrogen peroxide (H 2 O 2 )-induced apoptosis in rat BMSCs (rBMSCs) and the potential underlying mechanisms. The results demonstrated that gigantol pretreatment significantly inhibited H 2 O 2 -induced apoptosis of rBMSCs. rBMSCs were incubated with 600 µM H 2 O 2 in the absence or presence of different doses of gigantol (1-100 µM). Cell viability and apoptosis ratios were assessed by MTT assays and flow cytometry, respectively. Morphological alterations and reactive oxygen species were measured by the fluorescent-based methods of Hoechst staining and dichlorodihydrofluorescein diacetate, respectively. Furthermore, the protein levels of phosphorylated-protein kinase B (Akt), B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X (Bax), caspase-3 and caspase-9 were investigated by western blotting. Following incubation with H 2 O 2 for 2 h, gigantol significantly inhibited the H 2 O 2 -induced reductions in the cell viability of rBMSCs in a dose-dependent manner. Furthermore, gigantol upregulated Akt phosphorylation and Bcl-2 expression, downregulated Bax expression, and reduced the expression of caspase-3 and caspase-9 in H 2 O 2 -treated rBMSCs, whereas an opposite effect was detected when LY294002, an inhibitor of phosphatidylinositol 3-kinase, was administered in combination with gigantol. These results indicate that gigantol may be developed as a promising neuroprotective agent for successful MSC transplantation in ischemic diseases.
Introduction
Diseases associated with cerebral ischemia are a major cause of mortality in developing countries. Ischemic stroke is associated with the acute loss of neurons, astroglia and oligodendroglia, in addition to disruption to synaptic architecture, as a result of cerebral artery occlusion (1) . Certain studies have focused on the potential use of mesenchymal stem cell (MSC) transplantation in the treatment of central nervous system (CNS) diseases and injures, such as cerebral ischemia (2, 3) . MSC therapy is considered a novel and promising strategy for the treatment of ischemic stroke, and may exert neuroprotective effects and promote the repair of neurons by secreting various neural trophic factors and replacing damaged neurons (4) . However, the ischemic microenvironment negatively influences the survival rate of transplanted MSCs in injured CNS conditions due to oxidative stress (5, 6) . Thus, improving the survival of MSCs during oxidative stress may improve the efficacy of MSC-based therapies.
Gigantol is a biphenolic compound that is primarily extracted from the stem of Dendrobium aurantiacum (7) . Phenols derived from natural plants contain numerous antioxidants and therefore are typically used to study antioxidative activities (8) (9) (10) (11) . Furthermore, gigantol is reported to exhibit numerous biological functions, including anti-osmosis effects (12) , antitumor effects in human liver (13) and lung (14) cancer, antimutagenic effects (15) and immunomodulatory activities (16 Cell viability assay. Cells were seeded in 96-well plates (1x10 5 cells/ml) for 24 h at room temperature. To determine the effects of gigantol and H 2 O 2 on rBMSC viability, cells were treated with 1, 10, 40, 80 and 100 µM gigantol for 12 h, or 400, 500, 600, 700, 800 and 900 µM H 2 O 2 for 2 h, respectively. As a control, cells were treated with DMEM medium only. Furthermore, in another cell viability assay, cells were pretreated with different concentrations of gigantol (1, 10, 40, 80 and 100 µM) for 12 h followed by treatment with 600 µM H 2 O 2 for 2 h, both at room temperature. Subsequently, 20 µl MTT was added to each well and incubated at 37˚C for 4 h prior to removal and addition of 100 µl dimethyl sulfoxide. The absorbance value was measured in a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA) at 490 nm. Statistical analysis was performed on absorbance value readings.
Assessment of morphological changes. Cells were cultured in 24-well plates (5x10 5 cells/well) and treated with 80 µM gigantol for 12 h followed by the addition of 600 µM H 2 O 2 for 2 h. Cells in the H 2 O 2 group were treated with 600 µM H 2 O 2 only. Cells were fixed with 4% paraformaldehyde for 10 min and washed with PBS twice prior to staining with Hoechst 33258 for 5 min at 4˚C in the dark. Condensed nuclei and cell shrinkage were observed using an inverted and fluorescence microscope (Leica Microsystems GmbH, Wetzlar, Germany). A bright blue stain indicated apoptotic cell nuclei.
Measurement of ROS.
Cells were cultured in 6-well plates (1x10 6 cells/well) and treated with 80 µM gigantol for 12 h followed by the addition of 600 µM H 2 O 2 for 2 h, both at room temperature. Cells in the H 2 O 2 group were treated with 600 µM H 2 O 2 only. Cells were stained with 10 µM 2'7'-dichlorofluorescin diacetate (DCFH-DA) diluted with serum-free medium at 37˚C for 20 min and later washed with serum-free medium three times. Fluorescence intensity was analyzed using a microplate reader (Bio-Rad Laboratories, Inc.) at excitation and emission wavelengths of 488 and 525 nm, respectively. Images were captured using a fluorescence microscope (Leica Microsystems GmbH). The absorbance values were obtained for statistical analysis.
Flow cytometric analysis of cell apoptosis. Cells were seeded in 6-well plates (1x10 6 cells/well) for 24 h and and treated with 80 µM gigantol for 12 h followed by the addition of 600 µM H 2 O 2 for 2 h. Cells in the H 2 O 2 group were treated with 600 µM H 2 O 2 only. Subsequently, cells were harvested and washed twice using PBS, and were resuspended in 500 µl binding buffer. Annexin V-FITC stock (5 µl) and propidium iodide solution (5 µl) was added to the cells and incubated for 10 min at room temperature in the dark, and immediately analyzed using flow cytometer (BD FACSCanto II). The percentage of apoptotic cells was obtained for statistical analysis.
Protein extraction and western blot analysis. Cells were seeded in 6-well plates (1x10 6 cells/well) for 24 h and treated with 80 µM gigantol for 12 h followed by the addition of 600 µM H 2 O 2 for 2 h, both at room temperature. Cells in the H 2 O 2 group were treated with 600 µM H 2 O 2 only. Cells in the gigantol + H 2 O 2 + LY294002 group were pretreated with LY294002 (25 µmol/l) for 1 h prior to gigantol with H 2 O 2 treatment. Subsequently, cells were washed with PBS and lysed in cold radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology, Haimen, China) with protein inhibitor. Cellular proteins were collected and their concentrations were determined using a Bradford assay. Equal amounts of protein (40 µg/lane) were separated on 15% SDS-polyacrylamide gels and transferred onto polyvinylidene difluoride membranes via electrophoresis. After blocking with tris-buffered saline (TBS) containing 5% skimmed milk and 0.05% Tween-20 for 1 h at room temperature, the membranes were incubated with the following primary antibodies: p-Akt (ser 473; cat. no. Sc7985r; 1:100; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), Akt (ser 473; cat. no. Sc8312; 1:200; Santa Cruz Biotechnology, Inc.), B-cell lymphoma-2 (Bcl-2)-associated X (Bax; cat. no. 2772; 1:1,000; CST Biological Reagents Co., Ltd., Shanghai, China), Bcl-2 (cat. no. 2872; 1:1,000; CST Biological Reagents Co., Ltd.), Caspase-3 (cat. no. 9662; 1:1,000; CST Biological Reagents Co., Ltd.), Caspase-9 (cat. no. 9504; 1;1,000; CST Biological Reagents Co., Ltd.) and β-actin (cat. no. sc58673; Santa Cruz Biotechnology, Inc.) at 4˚C overnight. After washing with TBS three times, the membranes were incubated with goat anti-rabbit immunoglobulin G antibodies conjugated with horseradish peroxidase (cat. no. 111-035-003; 1:1,000; Jackson Immuno Research Laboratories, Inc., West Grove, PA, USA) for 1 h at room temperature. Following three washes with TBS-Tween-20, the intensity of bands was visualized using an enhanced chemiluminescence western blotting kit (Merck KGaA) and quantified by densitometric analysis with ImageJ software (version 3.0; National Institutes of Health, Bethesda, MD, USA).
Statistical analysis. All experiments were conducted at least three times. Data are presented as the mean + standard error of the mean. Differences among groups were analyzed by one-way analysis of variance, followed by Dunnett's post-hoc test, using SPSS version 20 (IBM Corp., Armonk, NY, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

Gigantol inhibits H 2 O 2 -induced inhibition of cell viability in rBMSCs.
To determine an appropriate concentration of gigantol, cells were treated with gigantol (1, 10, 40, 80 and 100 µM), and the results indicated that none of these concentrations exhibited a damaging effect on cell viability (Fig. 1B) . Cell viability was reduced in a dose-dependent manner when treated with 400, 500, 600, 700 and 800 µM H 2 O 2 for 2 h, compared with the control group. H 2 O 2 at the concentration of 600 µM significantly reduced cell viability compared with the control by 51.6±3.2% (Fig. 1C) . In addition, results in Fig. 1D demonstrated that gigantol significantly increased the cell (Fig. 1D) . Concentrations of gigantol >80 µM reduced the stimulatory effect. Therefore, 600 µM H 2 O 2 and 80 µM gigantol were selected for the following experiments.
Assessment of morphological changes. Following treatment with H 2 O 2 , apoptosis-associated morphology was observed in rBMSCs, including detachment, irregular shape and nuclear shrinkage. However, the number of apoptosis-like cells decreased in the group pretreated with gigantol, which indicated a potential protective effect of gigantol from apoptosis induction ( Fig. 2A and B) .
Detection of ROS. Cellular oxidative stress was examined by a DCFH-DA assay. The results demonstrated that, in the H 2 O 2 -treated group, a significant increase in 2',7'-dichlorofluorescein fluorescence was observed ( Fig. 2C and D) . However, pretreatment with gigantol significantly reduced the intracellular production of ROS compared with the H 2 O 2 -treated group (Fig. 2C and D) .
Analysis of cell apoptosis. Cell apoptosis was analyzed using an Annexin V and propidium iodide double-staining assay by flow cytometry. Fig. 4A and B) , and increased the levels of the proapoptotic proteins Bax, caspase-3 and caspase-9 ( Fig. 4B-D) . However, gigantol pretreatment lowered the caspase-3, caspase-9 and Bax levels, and increased the levels of p-Akt and Bcl-2, compared with the H 2 O 2 only group (Fig. 4) . Furthermore, LY294002 (a PI3K inhibitor) significantly inhibited the protective effect of gigantol against H 2 O 2 -induced apoptosis by increasing the levels of caspase-3, caspase-9 and the ratio of Bax/Bcl-2, and decreasing the ratio of p-Akt/Akt (Fig. 4) .
Discussion
Previous studies have reported that the transplantation of human or rat MSCs led to a substantial functional improvement in stroke treatment (20) (21) (22) . However, the low survival rate of MSCs that are transplanted for the treatment of an ischemic myocardium indicates that the hypoxic microenvironment may impair the survival of MSCs. H 2 O 2 has successfully been used to induce oxidative stress, which led to cell apoptosis and mimicked the hypoxic microenvironment of the ischemic brain (23) (24) (25) . In addition, Sun et al (26) employed a H 2 O 2 -induced cytotoxicity model of BMSCs to investigate damage induced by oxidative stress.
We previously reported that gigantol is abundant in Dendrobium aurantiacum among the herbal medicines grouped as Huangcao Shihu, which includes Dendrobium nobile, Dendrobium fimbriatum and Dendrobium aurantiacum (27) . It is uncommon for such high concentrations of active compounds to occur naturally within plants; therefore, gigantol may be of clinical value if beneficial effects are observed. The present study, to the best of our knowledge, is the first to indicate that gigantol may have protective activities against ischemic diseases, as MTT and flow cytometry results demonstrated that gigantol inhibited H 2 O 2 -induced cell apoptosis in rBMSCs. Furthermore, gigantol reduced the generation of ROS in H 2 O 2 -treated rBMSCs, which indicates that gigantol may exhibit beneficial antiapoptotic activities through inhibition of ROS generation.
A previous report demonstrated that extracellular H 2 O 2 enhanced intracellular concentrations of ROS, which subsequently inactivated p-Akt (28) . In the present study, treatment of MSCs with H 2 O 2 led to decreased levels of p-Akt, indicating that the PI3K/Akt signaling pathway may be inhibited in MSCs following exposure to H 2 O 2 . In the present study, treatment with gigantol activated the expression of p-Akt in H 2 O 2 -induced rBMSCs. Previous studies have demonstrated that the PI3K/Akt pathway is involved in various biological processes, including cell growth, survival and apoptosis, and also has roles in cell metabolism, proliferation and migration (29) (30) (31) .
PI3K/Akt is reported to prevent cell apoptosis by reducing the expression of various proapoptotic proteins, including caspase-3, caspase-9 and Bax, and by elevating the levels of the antiapoptotic protein Bcl-2 (32). These results are consistent with those of an earlier report, which indicated that PI3K-Akt signaling increased the intracellular levels of ROS and activated the proapoptotic proteins caspase-3, caspase-9 and Bax, and inhibited the expression of Bcl-2 (33) . The results of the current study demonstrated that H 2 O 2 treatment increased the Bax/Bcl-2 ratio, and caspase-3 and caspase-9 protein expression, in rBMSCs. However, pretreatment with gigantol suppressed the Bax/Bcl-2 ratio, and caspase-3 and caspase-9 levels, which indicates that gigantol may protect against rBMSC apoptosis via the PI3K/Akt signaling pathway. Furthermore, LY294002, a specific PI3K/Akt inhibitor, blocked the protective effects of gigantol. These results confirmed that PI3K/Akt may be activated by gigantol to protect rBMSCs from H 2 O 2 -induced apoptosis.
In conclusion, the present study demonstrated that gigantol significantly inhibited H 2 O 2 -induced apoptosis in rBMSCs. The protective effect of gigantol was accompanied by reductions in intracellular ROS generation, the expression ratio of Bax/Bcl-2, and caspase-3 and caspase-9 protein expression, in addition to increases in the ratio of p-Akt/Akt and Bcl-2 expression. Therefore, gigantol may have the potential to be developed as a protective agent for the clinical treatment of patients with ischemic diseases. Regarding the utilization of gigantol in ischemic stroke, however, further in vitro and in vivo experiments are required to investigate the effect of gigantol on transport and differentiation in rBMSCs.
